文献速递主动脉疾病

肌肉减少症与ASA评分同t-Branch装置治疗患者脊髓缺血的关联

The Association of Sarcopenia and ASA Score to Spinal Cord Ischemia in Patients Treated With the t-Branch Device.
PubMed 文献 · J Endovasc Ther · 2023-06-06

单中心回顾性观察研究纳入80例t-Branch装置治疗患者,按瘦腰大肌面积(LPMA)及ASA评分联合分层,低风险组脊髓缺血发生率3.5%(1/28),中风险组12.5%(2/16),高风险组25%(9/36),差异有统计学意义(p=0.049);多因素分析示中风险患者有发生脊髓缺血的风险(p=0.04)。作者认为ASA评分I-II或LPMA>350 cm²·HU的低风险患者脊髓缺血风险较低,联合分层可识别高危组。

要点

  • 80例t-Branch治疗患者中,低风险组脊髓缺血3.5%(1/28),中风险组12.5%(2/16),高风险组25%(9/36),p=0.049。
  • 多因素分析示中风险患者有发生脊髓缺血的风险(p=0.04)。
  • 作者认为ASA评分I-II或LPMA>350 cm²·HU的低风险患者脊髓缺血风险较低。

核心结论

  • 作者认为ASA评分I-II或LPMA>350 cm²·HU的低风险患者在接受t-Branch装置行分支腔内动脉瘤修复后发生脊髓缺血的风险较低。
  • 作者认为按ASA评分联合腰大肌面积与衰减进行分层,可识别分支腔内动脉瘤修复后脊髓缺血风险较高的患者组。

研究设计与样本

  • 单中心回顾性观察研究,纳入2018年1月1日至2020年9月30日期间接受t-Branch装置(Cook Medical,Bjaeverskov,丹麦)治疗的择期与紧急患者,数据按STROBE声明收集。
  • 共纳入80例患者,平均年龄71±9岁,男性占62.5%;胸腹主动脉瘤占72.5%(其中I-III型占42.5%);37例(46%)为紧急治疗。
  • 在术前CT血管造影动脉期测量腰大肌面积(cm²)与衰减(HU),以瘦腰大肌面积(LPMA)将患者分为3组,并进一步按ASA评分联合LPMA分层。

主要发现

  • 30天内死亡11例(14%);12例(15%)出现任何严重程度的脊髓缺血。
  • LPMA各组间唯一有统计学意义的差异为年龄,第3组较第1组和第2组年龄更大(67.1岁 vs 72.1岁 vs 73.5岁,p=0.004)。
  • ASA联合LPMA分层后,低风险28例、中风险16例、高风险36例,脊髓缺血发生率分别为3.5%(1/28)、12.5%(2/16)、25%(9/36),差异有统计学意义(p=0.049)。
  • 多因素分析显示中风险患者有发生脊髓缺血的风险(p=0.04)。

关键数值与推荐

  • 低风险组脊髓缺血3.5%(1/28) vs 中风险组12.5%(2/16) vs 高风险组25%(9/36),p=0.049。
  • 多因素分析中风险患者发生脊髓缺血 p=0.04。
  • LPMA分组年龄:第1组67.1岁 vs 第2组72.1岁 vs 第3组73.5岁,p=0.004。
  • 30天死亡11例(14%);脊髓缺血任何严重程度12例(15%)。

临床怎么用

  • 作者认为按ASA评分联合腰大肌面积与衰减进行分层,可识别分支腔内动脉瘤修复后脊髓缺血风险较高的患者组。
  • 作者认为肌肉减少症可能是预测复杂腔内修复患者围术期不良事件(死亡以外)的有价值标志物。
  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Sarcopenia has been identified as an independent predictor of mortality in patients with infrarenal abdominal aortic aneurysm and may also affect outcomes in patients with complex aortic pathologies. The aim of this study was to assess sarcopenia, combined with the American Society of Anesthesiologists (ASA) score, as predictors for spinal cord ischemia (SCI) in patients treated with the t-Branch off-the-shelf device. MATERIALS AND METHODS: A single-center retrospective observational study was conducted including elective and urgent patients managed with the t-Branch device (Cook Medical, Bjaeverskov, Denmark) between January 1, 2018, and September 30, 2020. Data were collected according to the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement. The psoas muscle area (cm2) and attenuation (Hounsfield units, HU) were measured in the arterial phase of the pre-operative computed tomography angiography for each patient. The lean psoas muscle area (LPMA) was used to stratify patients into 3 groups, and further stratification was performed with a combination of the ASA score and LPMA. RESULTS: Eighty patients were included (mean age at 71±9 years; 62.5% males). Thoracoabdominal aneurysms were managed in 72.5% of cases (42.5% for type I-III). Thirty-seven (46%) were treated urgently. Eleven patients died within 30 days (14%). Twelve patients (15%) presented SCI of any severity. Among the LPMA groups, the only statistically significant difference was recorded in age; group 3 was older compared with groups 1 and 2 (67.1 years vs 72.1 years vs 73.5 years, p=0.004). After ASA combined LPMA categorization, 28 patients were considered as low risk, 16 as moderate risk, and 36 as high risk. A statistically significant difference was recorded in terms of SCI (3.5% [1/28] in low risk vs 12.5% [2/16] in moderate risk vs 25% [9/36] in high risk, p=0.049). Multivariate analysis showed that moderate-risk patients were at risk to evolve to SCI (p=0.04). CONCLUSIONS: Low-risk patients, with ASA score I-II or LPMA>350cm2HU, are at lower risk for developing SCI after BEVAR using the t-Branch device. Patients' stratification according to the combination of ASA score and psoas muscle area and attenuation may identify a group at higher risk of SCI after branched endovascular aneurysm repair.Clinical ImpactSarcopenia has been identified as a factor of increased mortality in patients managed for aortic aneurysm repair. However, significant heterogeneity has been recorded in the tools assessing its presence. In this analysis, an already used method, combining the ASA score and psoas muscle area and attenuation, has been used to assess the impact of sarcopenia in patients managed with the t-branch device. This analysis showed that patients at low risk, with an ASA score I-II or LPMA>350cm2HU were at lower risk to evolve spinal cord ischemia. Along this line, sarcopenia may be a valuable marker for the prediction of perioperative adverse events, other than mortality, in patients managed using complex endovascular repair.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Kölbel T, Nana P, Torrealba JI, et al. The Association of Sarcopenia and ASA Score to Spinal Cord Ischemia in Patients Treated With the t-Branch Device. J Endovasc Ther. 2023. PMID: 37282511. doi:10.1177/15266028231179414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。